CareLit · DOI-Nachweis · Das Gesundheitswesen
Antiplatelet intake and risk for myocardial infarction
DOI 10.1055/s-0039-1694463
Bibliografische Angaben
Nachweis in CareLit
Autor:innenMacare, C.; Groos, S.; Kretschmann, J.; Weber, A.; Hagen, B.
ZeitschriftDas Gesundheitswesen
Ausgabe8/09/2019
Jahrgang / SeitenJg. 81 · S. 1 bis 1
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Myocardial infarction (MI) carries significant burden of disease and high mortality rates. Disease management programs (DMPs) have been implemented to reduce MI-related mortality through rigorous assessment of MI-related risk factors and secodary prevention. DMP tailored for coronary heart disease (CHD) specifies intake of antiplatelet medication as prevention to reduce MI occurrence. Aim: To assess al…
Zitieren
Zitierempfehlung
Macare, C.; Groos, S.; Kretschmann, J.; Weber, A.; Hagen, B (2019) Antiplatelet intake and risk for myocardial infarction. Das Gesundheitswesen, 81 (8/09), 1 bis 1. https://doi.org/10.1055/s-0039-1694463
Mit CareLit weiterarbeiten